0001161697-21-000025.txt : 20210104 0001161697-21-000025.hdr.sgml : 20210104 20210104164221 ACCESSION NUMBER: 0001161697-21-000025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201230 FILED AS OF DATE: 20210104 DATE AS OF CHANGE: 20210104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tierney David S CENTRAL INDEX KEY: 0001292636 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 21502302 MAIL ADDRESS: STREET 1: C/O ABLE LABORATORIES, INC. STREET 2: 6 HOLLYWOOD COURT, CN 1013 CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1250 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 1250 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 12-30-2020 X0306 4 2020-12-30 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001292636 Tierney David S 355 ALHAMBRA CIRCLE, SUITE 1250 CORAL GABLES FL 33134 1 0 0 0 Options to purchase common stock 3.42 2020-12-30 4 A 0 30000 0 A 2027-12-30 Common Stock 30000 356167 D Derivative securities vest in equal tranches, 1/3rd on December 30, 2021, 1/3rd on December 30, 2022 and 1/3rd on December 30, 2023. /s/ David S. Tierney 2021-01-04